We are live on ! Find out more
CA

Cullinan Associates Portfolio holdings

AUM $1.24B
1-Year Est. Return 28.12%
This Fund
S&P 500
This Quarter Est. Return
+1.81%
1 Year Est. Return
+28.12%
3 Year Est. Return
+86.66%
5 Year Est. Return
+111.98%
10 Year Est. Return
+372.59%
AUM
$1.17B
AUM Growth
+$4.34M
Cap. Flow
-$6.31M
Cap. Flow %
-0.54%
Top 10 Hldgs %
39.26%
Holding
205
New
5
Increased
76
Reduced
80
Closed
8

Top Buys

Rank Stock Value
1
JD icon
JD.com
JD
+$2.61M
2
SNY icon
Sanofi
SNY
+$2.39M
3
BMY icon
Bristol-Myers Squibb
BMY
+$2.28M
4
TPR icon
Tapestry
TPR
+$2.23M
5
PM icon
Philip Morris
PM
+$1.86M

Top Sells

Rank Stock Value
1
AFL icon
Aflac
AFL
+$9.87M
2
ABBV icon
AbbVie
ABBV
+$5.53M
3
VMC icon
Vulcan Materials
VMC
+$2.25M
4
UPS icon
United Parcel Service
UPS
+$1.98M
5
YUM icon
Yum! Brands
YUM
+$1.69M

Sector Composition

Rank Sector Weight
1 Consumer Staples 31.19%
2 Financials 11.71%
3 Healthcare 11.11%
4 Technology 10.83%
5 Industrials 9.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EPD icon
101
Enterprise Products Partners
EPD
$83B
$3.05M 0.26%
112,710
TJX icon
102
TJX Companies
TJX
$173B
$2.96M 0.25%
78,700
+2,000
+3% +$75.6K
BRK.B icon
103
Berkshire Hathaway Class B
BRK.B
$1.07T
$2.85M 0.24%
17,460
SWK icon
104
Stanley Black & Decker
SWK
$14.5B
$2.82M 0.24%
24,620
ZBH icon
105
Zimmer Biomet
ZBH
$18B
$2.79M 0.24%
27,892
+1,854
+7% +$199K
QCOM icon
106
Qualcomm
QCOM
$178B
$2.67M 0.23%
40,893
+1,900
+5% +$128K
PX
107
DELISTED
Praxair Inc
PX
$2.62M 0.22%
22,353
+60
+0.3% +$7.13K
TRV icon
108
Travelers Companies
TRV
$81.6B
$2.5M 0.21%
20,453
+1,437
+8% +$164K
SNY icon
109
Sanofi
SNY
$106B
$2.45M 0.21%
+60,660
New +$2.39M
FAST icon
110
Fastenal
FAST
$54.6B
$2.45M 0.21%
208,704
-23,696
-10% -$260K
DHR icon
111
Danaher
DHR
$137B
$2.38M 0.2%
34,545
-1,015
-3% -$70.5K
LLY icon
112
Eli Lilly
LLY
$1.07T
$2.33M 0.2%
31,690
-677
-2% -$50.4K
MAR icon
113
Marriott International
MAR
$100B
$2.27M 0.19%
27,500
INTU icon
114
Intuit
INTU
$84.3B
$2.1M 0.18%
18,315
+3,165
+21% +$354K
D icon
115
Dominion Energy
D
$61.9B
$2.04M 0.17%
26,676
+6,398
+32% +$472K
HIG icon
116
Hartford Financial Services
HIG
$38.6B
$2M 0.17%
41,940
CAT icon
117
Caterpillar
CAT
$395B
$1.96M 0.17%
21,130
-700
-3% -$63.4K
FITB
118
Fifth Third Bancorp
FITB
$51.6B
$1.92M 0.16%
71,140
-7,400
-9% -$177K
EOG icon
119
EOG Resources
EOG
$75.6B
$1.9M 0.16%
18,770
+6,110
+48% +$595K
A icon
120
Agilent Technologies
A
$38.9B
$1.81M 0.15%
39,750
+200
+0.5% +$9.07K
CRM icon
121
Salesforce
CRM
$144B
$1.76M 0.15%
25,720
-70
-0.3% -$5.08K
FLR icon
122
Fluor
FLR
$7.11B
$1.73M 0.15%
32,900
+1,300
+4% +$67.5K
BAC icon
123
Bank of America
BAC
$435B
$1.68M 0.14%
76,100
-1,700
-2% -$32.7K
GS icon
124
Goldman Sachs
GS
$306B
$1.53M 0.13%
6,400
-800
-11% -$162K
CERN
125
DELISTED
Cerner Corp
CERN
$1.52M 0.13%
+31,995
New +$1.7M

Similar funds

Cullinan Associates's Q4 2016 Portfolio in Review

As of Q4 2016, Cullinan Associates held 205 positions worth $1.17B, up 0.37% from $1.17B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Cullinan Associates's Q4 2016 filing shows 5 new, 76 increased, 80 reduced and 8 closed positions. Its largest new stake was Sanofi: 60,660 shares worth $2.45M. The largest sale was Aflac, an estimated $9.87M.

By sector, the portfolio is most concentrated in Consumer Staples at 31% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.

  • Cullinan Associates's largest Q4 2016 buy was Sanofi: 60,660 shares worth $2.45M.
  • Cullinan Associates added most to JD.com in Q4 2016, an estimated $2.61M increase.
  • Cullinan Associates's biggest Q4 2016 reduction was Aflac, cutting an estimated $9.87M.
  • Cullinan Associates fully exited Vulcan Materials in Q4 2016, selling an estimated $2.25M.
  • Cullinan Associates's ten largest holdings make up 39% of its $1.17B portfolio in Q4 2016.
  • Cullinan Associates opened 5 new positions and closed 8 in Q4 2016.
  • Cullinan Associates's portfolio value rose 0.37% quarter-over-quarter to $1.17B.

Based on Cullinan Associates's 13F filing for Q4 2016, filed 30 Jan 2017.